TY - JOUR
T1 - Preoperative evaluation of renal cell carcinoma patients with bone metastases on risks for blood loss, performance status and lethal event
AU - Yoshiyama, Akira
AU - Morii, Takeshi
AU - Susa, Michiro
AU - Morioka, Hideo
AU - Kobayashi, Eisuke
AU - Asano, Naofumi
AU - Mori, Tomoaki
AU - Anazawa, Ukei
AU - Watanabe, Itsuo
AU - Takeuchi, Katsuhito
AU - Kushima, Yu
AU - Aoyagi, Takayuki
AU - Ichimura, Shoichi
N1 - Funding Information:
We thank Tomohiro Shinozaki (Department of Biostatistics, School of Public Health, the University of Tokyo, Tokyo) for his helpful suggestion on statistical analysis of the data in this study. This research was supported by the Practical Research for Innovative Cancer Control from the Japan Agency for Medical Research and Development ( 16ck0106087h0003 ).
Publisher Copyright:
© 2017 The Japanese Orthopaedic Association
PY - 2017/9
Y1 - 2017/9
N2 - Background Surgical treatment for renal cell carcinoma metastases can be an effective modality for improving survival and patients' quality of life. However, it is often difficult to decide on the optimal surgical approach due to the lesion's high vascularity and uncertainty regarding postoperative performance status and survival. Patients and methods Blood loss, postoperative performance status, overall survival, postoperative complication and related risk factors for surgical treatment were analysed in 61 renal cell carcinoma patients with bone metastases. Results Pelvic location and impending/pathological fracture in the metastatic lesion were both significant risk factors for increased blood loss. An unresectable primary lesion and poor preoperative performance status were independent risk factors for poor postoperative performance status. A shorter duration from the discovery of primary lesion to bone metastasis, the number of metastases, and unresectable primary lesion were independent risk factors for shorter survival. Postoperative complications were identified in 15 cases (24.6%). Conclusion The preoperative prediction of intraoperative blood loss, performance status and survival in renal cell carcinoma patients with bone metastases may be possible based on the risk factors identified in this study.
AB - Background Surgical treatment for renal cell carcinoma metastases can be an effective modality for improving survival and patients' quality of life. However, it is often difficult to decide on the optimal surgical approach due to the lesion's high vascularity and uncertainty regarding postoperative performance status and survival. Patients and methods Blood loss, postoperative performance status, overall survival, postoperative complication and related risk factors for surgical treatment were analysed in 61 renal cell carcinoma patients with bone metastases. Results Pelvic location and impending/pathological fracture in the metastatic lesion were both significant risk factors for increased blood loss. An unresectable primary lesion and poor preoperative performance status were independent risk factors for poor postoperative performance status. A shorter duration from the discovery of primary lesion to bone metastasis, the number of metastases, and unresectable primary lesion were independent risk factors for shorter survival. Postoperative complications were identified in 15 cases (24.6%). Conclusion The preoperative prediction of intraoperative blood loss, performance status and survival in renal cell carcinoma patients with bone metastases may be possible based on the risk factors identified in this study.
UR - http://www.scopus.com/inward/record.url?scp=85029045052&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85029045052&partnerID=8YFLogxK
U2 - 10.1016/j.jos.2017.07.006
DO - 10.1016/j.jos.2017.07.006
M3 - Article
C2 - 28784566
AN - SCOPUS:85029045052
SN - 0949-2658
VL - 22
SP - 924
EP - 930
JO - Journal of Orthopaedic Science
JF - Journal of Orthopaedic Science
IS - 5
ER -